Obviously, it will go down, but how far and how long depneds on multiple variables. It depends on which study, but I'll assume you mean Type 1 is successful and type 2 and early stage fails. Is it a simple matter of clarification or is it a safety issue (which could be the end of the line)? Do they have a partner that will fund new studies or will they dilute?